Concentra Group Holdings Parent, Inc.
NYSE:CONMedical - Equipment & Services
+$0.15 today
- Market cap
- $5.31B
- Beta
- 0.82
- P/E (TTM)
- 20.3
- EPS (TTM)
- $1.41
- Dividend yield
- 0.88%
Volume 0.74M
Average 0.90M
CON Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Concentra Group Holdings Parent, Inc.NYSE: CON
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How CON compares with its peers on the latest reported figures
- CON's LTM Sep 2026 research & development of $0 is the 8th highest of the 10 companies compared; the peer median is $59.46M.
- Research & development amounts to 0.0% of revenue for CON, versus a peer median of 4.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $634M | +1.3% | +5.9% | 5.8% | |
| LTM Jun 2026 | $408.66M | +3.1% | +9.5% | 261.9% | |
| LTM Jun 2025 | $190.1M | -25.1% | -15.0% | 31.6% | |
| LTM Mar 2026 | $158M | -0.6% | -4.8% | 4.3% | |
| LTM Jun 2026 | $59.46M | -4.4% | +0.6% | 4.4% | |
| LTM Jul 2026 | $48.58M | -4.7% | -8.1% | 2.6% | |
| LTM Mar 2026 | $11.48M | -17.7% | -13.7% | 1.9% | |
CONConcentra Group Holdings Parent, Inc. | LTM Sep 2026 | $0 | — | — | 0.0% |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CON) | $59.46M | -4.4% | -4.8% | 4.3% | |
Competitors are the stored peer set for CON. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.73B | 1.72B | 1.84B | 1.9B | 2.16B |
| Cost of Revenue | 1.3B | 1.32B | 1.33B | 1.37B | 1.55B |
| Gross Profit | 427.98M | 408.19M | 512.43M | 527.98M | 613.09M |
| Gross Margin | 24.7% | 23.7% | 27.9% | 27.8% | 28.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 157.71M | 149.98M | 152M | 156.32M | 203.31M |
| Operating Expenses | 157.71M | 149.98M | 224.8M | 223.21M | 279.1M |
| Depreciation & Amortization | 82.21M | 73.67M | 73.05M | 67.18M | 75.82M |
| EBITDA | 389.63M | 330.2M | 360.16M | 368.27M | 408.93M |
| EBITDA Margin | 22.5% | 19.1% | 19.6% | 19.4% | 18.9% |
| Operating Income | 270.27M | 258.22M | 287.63M | 304.76M | 333.99M |
| Operating Margin | 15.6% | 15.0% | 15.6% | 16.0% | 15.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 31.86M | 31.64M | 114.04M | 69.69M | 109.29M |
| Other Income / Expenses | 5.3M | (33.32M) | (45M) | (73.37M) | (110.17M) |
| Income Before Tax | 275.56M | 224.9M | 242.63M | 231.39M | 223.83M |
| Pre-Tax Margin | 15.9% | 13.0% | 13.2% | 12.2% | 10.3% |
| Income Tax Expense | 59.53M | 52.65M | 57.89M | 59.5M | 50.98M |
| Net Income | 208.88M | 166.73M | 179.95M | 166.54M | 166.42M |
| Net Margin | 12.1% | 9.7% | 9.8% | 8.8% | 7.7% |
| EPS (Basic) | 1.65 | 1.32 | 1.42 | 1.30 | 1.39 |
| EPS (Diluted) | 1.65 | 1.32 | 1.42 | 1.30 | 1.30 |
| Weighted Avg Shares | 126.59M | 126.59M | 126.59M | 128.13M | 126.65M |
| Weighted Avg Shares (Diluted) | 126.59M | 126.59M | 126.59M | 128.13M | 128.17M |
Concentra Group Holdings Parent, Inc.
NYSE:CON
Intrinsic Alpha fair value
Locked
Current Price
$41.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.